In general, patients with the following characteristics may be good candidates for Tirzepatide: A Body Mass Index (BMI) of 30 or higher A Body Mass Index (BMI) of 27 or higher when at least one comorbidity is present, such as insulin resistance, hypertension, high cholesterol, sleep apnea, or gout
It slows gastric emptying
Full-text articles were then obtained for those that appeared relevant or where eligibility was uncertain
An authorized generic is different from a generic drug, according to the FDA, because its the exact same drug product as a branded drug, just without the brand name on the label
Compounding must be done under the framework of either Section 503A (traditional compounding pharmacies) or Section 503B (outsourcing facilities) of the Federal Food, Drug, and Cosmetic Act
You should not use GLP-1 medications if you have: Personal or family history of medullary thyroid cancer Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Previous severe allergic reaction to semaglutide or liraglutide Current pregnancy or planning to become pregnant History of pancreatitis (requires careful evaluation) Severe gastrointestinal disease Additionally, these medications are not typically recommended for patients under 18 years old, though Saxenda has some pediatric approval for adolescents 12 and older with obesity
